Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases

dc.contributor.authorYuan, Yu-Guo
dc.contributor.authorWang, Jia-Lin
dc.contributor.authorZhang, Ya-Xin
dc.contributor.authorLi, Ling
dc.contributor.authorReza, Abu Musa Md Talimur
dc.contributor.authorGurunathan, Sangiliyandi
dc.date.accessioned2025-10-29T11:09:47Z
dc.date.issued2023
dc.departmentGebze Teknik Üniversitesi
dc.description.abstractExosomes are nanovesicles with a wide range of chemical compositions used in many different applications. Mesenchymal stem cell-derived exosomes (MSCs-EXOs) are spherical vesicles that have been shown to mediate tissue regeneration in a variety of diseases, including neurological, autoimmune and inflammatory, cancer, ischemic heart disease, lung injury, and liver fibrosis. They can modulate the immune response by interacting with immune effector cells due to the presence of anti-inflammatory compounds and are involved in intercellular communication through various types of cargo. MSCs-EXOs exhibit cytokine storm-mitigating properties in response to COVID-19. This review discussed the potential function of MSCs-EXOs in a variety of diseases including neurological, notably epileptic encephalopathy and Parkinson's disease, cancer, angiogenesis, autoimmune and inflammatory diseases. We provided an overview of exosome biogenesis and factors that regulate exosome biogenesis. Additionally, we highlight the functions and potential use of MSCs-EXOs in the treatment of the inflammatory disease COVID-19. Finally, we covered a strategies and challenges of MSCs-EXOs. Finally, we discuss conclusion and future perspectives of MSCs-EXOs.
dc.description.sponsorshipPriority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JBGS (2021) 025]
dc.description.sponsorship111 Project
dc.description.sponsorshipYangzhou University corporation [D18007]
dc.description.sponsorship[YZ2021161/YZ2022187]
dc.description.sponsorshipThis study was supported by Development of a new precise cytosine base editor (JBGS (2021) 025) , the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) , the 111 Project D18007, and Yangzhou city and Yangzhou University corporation (YZ2021161/YZ2022187) .
dc.identifier.doi10.2147/IJN.S407029
dc.identifier.endpage3210
dc.identifier.issn1178-2013
dc.identifier.orcid0000-0001-9924-8433
dc.identifier.pmid37337578
dc.identifier.scopus2-s2.0-85162712838
dc.identifier.scopusqualityQ1
dc.identifier.startpage3177
dc.identifier.urihttps://doi.org/10.2147/IJN.S407029
dc.identifier.urihttps://hdl.handle.net/20.500.14854/5988
dc.identifier.volume18
dc.identifier.wosWOS:001013227700001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherDove Medical Press Ltd
dc.relation.ispartofInternational Journal of Nanomedicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20251020
dc.subjectextracellular vesicle
dc.subjectbiogenesis
dc.subjectmesenchymal stem cells
dc.subjectexosomes
dc.subjectautoimmune disease
dc.subjectangiogenesis
dc.titleBiogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases
dc.typeReview Article

Dosyalar